![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/the-valens-company-granted-additional-180-calendar-day-grace-period-by-nasdaq-to-regain-compliance-with-minimum-bid-price-rule-301702320.html
https://www.prnewswire.com/news-releases/valens-shareholders-vote-in-favour-of-the-arrangement-with-sndl-301689513.html
https://www.prnewswire.com/news-releases/both-leading-independent-proxy-advisors-recommend-shareholders-of-the-valens-company-inc-vote-for-the-proposed-arrangement-with-sndl-inc-301684914.html
https://www.prnewswire.com/news-releases/valens-secures-sales-licence-for-greater-toronto-area-beverage-facility-301666851.html
https://www.prnewswire.com/news-releases/the-valens-company-announces-mailing-and-filing-of-circular-for-special-meeting-of-shareholders-to-approve-arrangement-with-sndl-inc-301661826.html
https://www.prnewswire.com/news-releases/the-valens-company-reports-third-quarter-fiscal-2022-financial-results-301648452.html
https://www.prnewswire.com/news-releases/sndl-announces-agreement-to-acquire-the-valens-company-to-create-leading-vertically-integrated-cannabis-platform-301609899.html
https://www.prnewswire.com/news-releases/the-valens-company-reports-second-quarter-fiscal-2022-financial-results-301586218.html
https://www.prnewswire.com/news-releases/the-valens-company-signs-exclusive-cannabis-partnership-with-coldhaus-distribution-301572925.html
https://www.prnewswire.com/news-releases/the-valens-company-continues-to-expand-canadian-recreational-market-share-in-april-301554557.html